Non-curative gastric resection for patients with stage 4 gastric cancer - A single center experience and current review of literature

Langenbeck's Archives of Surgery

Volumn 397, Issue 5, 2012, Pages 745-753

  Dittmar, Yves ^a   Rauchfuss, Falk ^a   Goetz, Max ^a   Jandt, Karin ^a   Scheuerlein, Hubert ^a   Heise, Michael ^a   Settmacher, Utz ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Chemotherapy; Gastric cancer; Non curative gastric resection; Survival

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGE; AGED; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COMPLICATION; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HOSPITAL PATIENT; HUMAN; INCIDENCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON CURATIVE GASTRIC RESECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; STOMACH CANCER; SURVIVAL TIME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CAUSE OF DEATH; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; GASTRECTOMY; GERMANY; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT FAILURE; YOUNG ADULT;

EID: 84863983352     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-012-0902-3     Document Type: Review

References (47)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ (2004) Cancer statistics, 2004. CA Cancer J Clin 54(1):8-29
2. Roukos DH, Kappas AM (2005) Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2(2):98-107. doi:10.1038/ncponc0099
3. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC (1989) Peritoneal carcinomatosis in nongynecologic malignancy: a prospective study of prognostic factors. Cancer 63(2):364-367
4. Feng XY, Chen YB, Chen S, Li YF, Zhou ZW, Li W, Zhan YQ, Sun XW, Xu DZ, Guan YX (2010) Relationship between the number of lymph node detection and prognosis in stage II (gastric cancer after D (2) dissection. Zhonghua Wei Chang Wai Ke Za Zhi 13(5):346-349
5. Hundahl SA, Phillips JL, Menck HR (2000) The National Cancer Data Base Report on poor survival of U. S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 88(4):921-932. doi:10.1002/(SICI)1097-0142(20000215) 88:4<921::AID-CNCR24>3.0. CO;2-S
6. Coburn NG (2009) Lymph nodes and gastric cancer. J Surg Oncol 99(4):199-206. doi:10.1002/jso.21224
7. Kim MC, Kim HH, Jung GJ, Lee JH, Choi SR, Kang DY, Roh MS, Jeong JS (2004) Lymphatic mapping and sentinel node biopsy using 99mTc tin colloid in gastric cancer. Ann Surg 239(3):383-387
8. Shah MA, Kelsen DP (2010) Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. J Natl Compr Canc Netw 8(4):437-447
9. Wagner AD, Unverzagt S, Grothe W, Kleber G, Grothey A, Haerting J, Fleig WE (2010) Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev 3:CD004064. doi:10.1002/14651858.CD004064.pub3
10. Nishiyama M, Wada S (2009) Docetaxel: its role in current and future treatments for advanced gastric cancer. Gastric Cancer 12(3):132-141. doi:10.1007/s10120-009-0521-z
11. Meza-Junco J, Au HJ, Sawyer MB (2009) Trastuzumab for gastric cancer. Expert Opin Biol Ther 9(12):1543-1551. doi:10.1517/14712590903439702
12. Lawrence W Jr, Mc NG (1958) The effectiveness of surgery for palliation of incurable gastric cancer. Cancer 11(1):28-32
13. ReMine WH (1979) Palliative operations for incurable gastric cancer. World J Surg 3(6):721-729
14. Bozzetti F, Bonfanti G, Audisio RA, Doci R, Dossena G, Gennari L, Andreola S (1987) Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet 164(2):151-154
15. Hartgrink HH, Putter H, Klein Kranenbarg E, Bonenkamp JJ, van de Velde CJ (2002) Value of palliative resection in gastric cancer. Br J Surg 89(11):1438-1443. doi:10.1046/j.1365-2168.2002.02220.x
16. Lin SZ, Tong HF, You T, Yu YJ, Wu WJ, Chen C, Zhang W, Ye B, Li CM, Zhen ZQ, Xu JR, Zhou JL (2008) Palliative gastrectomy and chemotherapy for stage IV gastric cancer. J Cancer Res Clin Oncol 134(2):187-192. doi:10.1007/s00432-007- 0268-z
17. Huang KH, Wu CW, Fang WL, Chen JH, Lo SS, Wang RF, Li AF Palliative resection in noncurative gastric cancer patients. World J Surg 34(5):1015-1021. doi:10.1007/s00268-010-0467-7
18. Miner TJ, Jaques DP, Karpeh MS, Brennan MF (2004) Defining palliative surgery in patients receiving noncurative resections for gastric cancer. J Am Coll Surg 198(6):1013-1021. doi:10.1016/j.jamcollsurg.2004.02.007S1072-7515(04) 00149-8
19. Moehler M, Galle PR, Gockel I, Junginger T, Schmidberger H (2007) The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer. Best Pract Res Clin Gastroenterol 21(6):965-981. doi:10.1016/j.bpg.2007.10.003
20. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31-49
21. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187-196. doi:10.1097/SLA.0b013e3181b13ca2
22. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205-213
23. Kunisaki C, Makino H, Takagawa R, Oshima T, Nagano Y, Fujii S, Otsuka Y, Akiyama H, Ono HA, Kosaka T, Ichikawa Y, Shimada H (2008) Impact of palliative gastrectomy in patients with incurable advanced gastric cancer. Anticancer Res 28(2 B):1309-1315
24. Wang CS, Chao TC, Jan YY, Jeng LB, Hwang TL, Chen MF (2002) Benefits of palliative surgery for far-advanced gastric cancer. Chang Gung Med J 25(12):792-802
25. Sarela AI, Miner TJ, Karpeh MS, Coit DG, Jaques DP, Brennan MF (2006) Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma. Ann Surg 243(2):189-195. doi:10.1097/01.sla.0000197382.43208.a500000658- 200602000-00007
26. Meyer L R K, Meyer F, Gastinger I, Lippert H (2008) Qualitä tssicherungsstudie zum Magenkarzinom in Deutschland. der Onkologe 14:396-402. doi:10.1007/s00761-008-1340-2
27. Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y, Mikuni J, Yamanami H (1998) Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 69(1):41-44. doi:10.1002/(SICI)1096-9098(199809) 69:1<41::AID-JSO8>3.0. CO;2-K
28. Adachi Y, Aramaki M, Shiraishi N, Shimoda K, Yasuda K, Kitano S (1998) Long-term survival after perforation of advanced gastric cancer: case report and review of the literature. Gastric Cancer 1(1):80-83. doi:10.1007/s101209800024
29. Mizutani S, Shioya T, Maejima K, Yoshino M, Komine O, Bou H, Ogata M, Watanabe M, Shibuya T, Tokunaga A, Tajiri T (2007) Significance of gastrectomy as palliative surgery for gastric carcinoma with pyloric stenosis. J Nippon Med Sch 74(3):241-245
30. Onate-Ocana LF, Mendez-Cruz G, Hernandez-Ramos R, Becker M, Carrillo JF, Herrera-Goepfert R, Aiello-Crocifoglio V, Ochoa-Carrillo F, Beltran-Ortega A (2007) Experience of surgical morbidity after palliative surgery in patients with gastric carcinoma. Gastric Cancer 10(4):215-220. doi:10.1007/s10120-007- 0437-4
31. Lim S, Muhs BE, Marcus SG, Newman E, Berman RS, Hiotis SP (2007) Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups? J Surg Oncol 95(2):118-122. doi:10.1002/jso.20328
32. Nazli O, Yaman I, Tansug T, Isguder AS, Bozdag AD, Bolukbasi H (2007) Palliative surgery for advanced stage (stage IV) gastric adenocarcinoma. Hepatogastroenterology 54(73):298-303
33. Saidi RF, ReMine SG, Dudrick PS, Hanna NN (2006) Is there a role for palliative gastrectomy in patients with stage IV gastric cancer? World J Surg 30(1):21-27. doi:10.1007/s00268-005-0129-3
34. Medina-Franco H, Contreras-Saldivar A, Ramos-De La Medina A, Palacios-Sanchez P, Cortes-Gonzalez R, Ugarte JA (2004) Surgery for stage IV gastric cancer. Am J Surg 187(4):543-546. doi:10.1016/j.amjsurg.2003.12.045
35. Monson JR, Donohue JH, McIlrath DC, Farnell MB, Ilstrup DM (1991) Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer 68(9):1863-1868
36. Meijer S, De Bakker OJ, Hoitsma HF (1983) Palliative resection in gastric cancer. J Surg Oncol 23(2):77-80
37. Yao Z, Mishra L (2009) Cancer stem cells and hepatocellular carcinoma. Cancer Biol Ther 8(18):1691-1698
38. Tan S, Chen JS, Sun LJ, Yao HR (2009) Selective enrichment of hepatocellular cancer stem cells by chemotherapy. J Int Med Res 37(4):1046-1056
39. Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, Shetty K, Johnson L, Reddy EP (2009) Liver stem cells and hepatocellular carcinoma. Hepatology 49(1):318-329. doi:10.1002/hep.22704
40. Koller M, Kussmann J, Lorenz W, Rothmund M (1994) Measuring quality of life in after-care of tumor surgery. Methods, problems and applications. Chirurg 65(4):333-339
41. Gilbertsen VA (1969) Results of treatment of stomach cancer. An appraisal of efforts for more extensive surgery and a rort of 1, 983 cases. Cancer 23(6):1305-1308
42. Yu D, Hung MC (2000) Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 19(53):6115-6121. doi:10.1038/sj.onc. 1203972
43. Dittmar Y, Posorski N, Rauchfuss F, Voigt R, Heise M, Jandt K, Gajda M, Settmacher U (2010) Relationship between degree of chromosomal aberration and survival in intestinal-type gastric cancer-a preliminary report based on three cases of hepatic metastasized gastric cancer with long-time survival. Onkologie 33(11):591-596. doi:10.1159/000321143
44. Sugarbaker PH, Yu W, Yonemura Y (2003) Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 21(4):233-248. doi:10.1002/ssu.10042
45. Glockzin G, Schlitt HJ, Piso P (2009) Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 7:5. doi:10.1186/1477-7819-7-5
46. Iesalnieks I, Kullmann F, Dahlke M, Ghali N, Agha A, von Breitenbuch P, Schoelmerich J, Schlitt HJ, Piso P (2006) Surgical management of patients with peritoneal carcinomatosis of gastrointestinal origin. Z Gastroenterol 44(12):1237-1245. doi:10.1055/s-2006-927156
47. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359-374